SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $44,000 | -81.7% | 61,000 | -69.1% | 0.03% | -72.1% |
| Q1 2019 | $240,000 | +2300.0% | 197,564 | +733.4% | 0.12% | +1933.3% |
| Q4 2018 | $10,000 | -90.2% | 23,706 | -53.3% | 0.01% | -87.0% |
| Q3 2018 | $102,000 | -46.9% | 50,759 | -44.1% | 0.05% | -37.0% |
| Q2 2018 | $192,000 | -59.7% | 90,781 | -48.1% | 0.07% | -59.0% |
| Q1 2018 | $476,000 | -15.8% | 175,000 | +14.2% | 0.18% | -17.2% |
| Q4 2017 | $565,000 | +81.7% | 153,231 | -4.5% | 0.22% | +93.7% |
| Q3 2017 | $311,000 | -6.9% | 160,399 | +29.7% | 0.11% | -29.3% |
| Q2 2017 | $334,000 | -32.1% | 123,643 | +3.1% | 0.16% | -29.0% |
| Q1 2017 | $492,000 | +12.6% | 119,881 | -0.8% | 0.22% | -10.5% |
| Q4 2016 | $437,000 | – | 120,807 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,134,926 | $3,375,000 | 3.69% |
| Aisling Capital Management LP | 10,100,000 | $4,190,000 | 1.82% |
| Samsara BioCapital, LLC | 5,938,215 | $2,464,000 | 1.42% |
| Corriente Advisors, LLC | 3,021,692 | $1,254,000 | 1.35% |
| MPM BioImpact LLC | 2,809,912 | $1,166,000 | 0.71% |
| Burrage Capital Management LLC | 682,586 | $280,000 | 0.28% |
| Avidity Partners Management LP | 4,310,000 | $1,788,000 | 0.25% |
| BVF INC/IL | 6,194,925 | $2,570,000 | 0.24% |
| Nantahala Capital Management | 9,566,844 | $3,969,000 | 0.15% |
| Worth Venture Partners, LLC | 362,330 | $150,000 | 0.09% |